NANDHINI SUNDARESAN

Dr. NANDHINI SUNDARESAN


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Asian Journal of Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
RRR Radha
R Radha
RVR Vadivu
R Vadivu
The present study deals with docking of Hematoporphrin with various anticancer drugs targeting enzymes. The targets used were PDB-ID 2Y3I, PDB-ID 3OZZ, PDB-ID 3UEN and PDB-ID 4O33. Hematoporphyrin docked with these enzymes and interactions between the enzyme and compound were measured and compared with standard Paclitaxel. The study concluded that, the compound (Hematoporphyrin) isolated from plant were high interactions with PDB-ID 4O33 when compared to standard.

31 May 2025 in Odontology
Verified
Journal Article
Closed access
PDF file
VLVamsi Lavu
Vamsi Lavu
SDS. Devi
S. Devi
DRDEEPAK RAVINDRAN
DEEPAK RAVINDRAN
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
SPS. Devaraja Dravida Pandiyan
S. Devaraja Dravida Pandiyan
CAChetan Ashok
Chetan Ashok

1 January 2025 in International Journal of Advancement in Life Sciences Research
Verified
Journal Article
Open access
PDF file
AKAswin Krishnamurthy
Aswin Krishnamurthy
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
VGVivekananthan Govindaraj
Vivekananthan Govindaraj
SRSanjay Raamakrishnan
Sanjay Raamakrishnan
MJMonish Janarthanan
Monish Janarthanan
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterised by the loss of dopamine-producing neurons in the brain, resulting in motor disturbances such as tremors, rigidity, and slowed movement. Although current therapies can improve symptoms, many patients experience side effects and a gradual decline in treatment effectiveness over time. This study employs comprehensive in silico methods to evaluate the therapeutic potential of ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), two bile acids with emerging neuroprotective properties. Molecular docking studies were conducted using AutoDock 1.5.7 software, and the ADMET properties of the compounds were assessed using SwissADME. Toxicity analyses of UDCA and TUDCA were performed using T.E.S.T 5.1.2 software. Molecular dynamics (MD) simulations of UDCA–protein complexes were carried out via the iMOD server and CABS-flex V 2.0. Molecular docking simulations revealed promising interactions between UDCA and TUDCA with Parkinson’s disease-associated proteins selected from the literature, including 1XQ8, 6CM4, 6RKB, and 4PYK. UDCA generally exhibited stronger binding affinities of −5.38, −8.99, −8.21, and −6.50 kcal/mol compared to TUDCA (−5.08, −7.07, −8.30, −5.94 kcal/mol), except in the case of MAO-B. Molecular dynamics simulations further supported the stability of the UDCA–protein complexes, with eigenvalues calculated as 3.97×10⁻⁷, 2.39×10⁻⁶, 1.59×10⁻⁵, and 9.02×10⁻⁵. Pharmacokinetic analyses indicated favourable properties for both UDCA and TUDCA, including high oral bioavailability and blood–brain barrier permeability. UDCA displayed slightly higher toxicity in aquatic organisms but exhibited comparable developmental and mutagenic risks to TUDCA. Collectively, these computational findings highlight the multi-target potential of UDCA and TUDCA in modulating neuroinflammatory processes, mitigating oxidative stress, and supporting mitochondrial integrity—mechanistic pathways central to PD pathogenesis.

31 July 2026 in Annals of Clinical Nutrition and Metabolism
Verified
Journal Article
Open access
AKAswin Krishnamurthy
Aswin Krishnamurthy
NSNandhini Sundaresan
Nandhini Sundaresan
VGVivekananthan Govindaraj
Vivekananthan Govindaraj
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
Purpose: Micronutrients play critical and multifaceted roles in the biological processes governing endodontic healing. This review aimed to evaluate the therapeutic roles of essential micronutrients, including vitamin D, vitamin C, calcium, zinc, magnesium, and selenium, in modulating immune responses, promoting tissue repair, and enhancing bone regeneration during endodontic healing.Current concept: The findings indicate that vitamin D supports odontoblast differentiation, immune regulation, and modulation of inflammatory pathways, whereas vitamin C enhances collagen synthesis, antioxidant protection, and pulp regeneration. Calcium and phosphorus are vital for hydroxyapatite formation and dentin mineralization, whereas zinc contributes to immune balance, enzymatic activation, and wound repair. Magnesium exhibits anti-inflammatory and bone-supportive properties, and selenium provides antioxidant and antimicrobial defense. Clinical studies have associated micronutrient deficiencies with delayed healing, increased infection risk, and reduced treatment success. Emerging innovations, such as bioactive sealants that release therapeutic minerals and diagnostic tools for nutrient profiling, highlight new directions in personalized endodontic care.Conclusion: Integrating micronutrient assessment and targeted supplementation strategies into clinical endodontic practice may optimize healing responses, minimize inflammation, and improve long-term treatment outcomes.

15 October 2026 in Research Journal of Pharmacognosy and Phytochemistry
Verified
Journal Article
Closed access
AKAswin Krishnamurthy
Aswin Krishnamurthy
DMDarshan Murugan
Darshan Murugan
MRM Mohammed Wasiq Rahman
M Mohammed Wasiq Rahman
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
Influenza virus remains a major global health threat, causing millions of infections and hundreds of thousands of deaths annually. The emergence of resistance to conventional antiviral drugs, including oseltamivir, underscores the need for novel therapeutic options. This study evaluates the potential of three olive-derived phytoconstituents—oleuropein, verbascoside, and hydroxytyrosol—as inhibitors of influenza virus neuraminidase. Advanced molecular docking revealed that verbascoside exhibited the highest binding affinity (−8.9 kcal/mol), surpassing oseltamivir (−5.5 kcal/mol), indicating superior neuraminidase inhibition. Pharmacokinetic assessments using SwissADME and pkCSM demonstrated favorable drug-likeness, absorption, and metabolic profiles for these compounds, supporting their therapeutic viability. Olive polyphenols are known for their anti-inflammatory, antioxidant, and cardioprotective properties, this study highlights their potential as natural anti-influenza agents with enhanced binding efficacy compared to standard antivirals. These findings suggest that olive-derived compounds, particularly verbascoside, may serve as promising alternatives for combating influenza, especially in cases of antiviral resistance.